Today: 24 January 2026
Subscribe
Browse Category

Financial Analysis News 20 November 2025 - 21 November 2025

BAE Systems share price today, 20 November 2025: UK defence giant climbs as India deal and space-chip tie-up support rebound

BAE Systems share price today, 21 November 2025: LON: BA. slides as defence stocks sell off despite fresh Denmark CV90 deal

BAE Systems plc (LON: BA.), the FTSE 100 defence heavyweight, traded lower on Friday, 21 November 2025, even as the company announced a fresh armoured‑vehicle contract with Denmark and deepened its role in cutting‑edge air and naval programmes. According to live pricing from the London Stock Exchange, BAE Systems shares were recently changing hands at around 1,715–1,720p, down roughly 2–2.3%…
21 November 2025
···
BP PLC share price: What to know before the London market opens on 17 November 2025

BP share price today (21 November 2025): BP.L dips as Olympic Pipeline shutdown and weaker oil prices hit sentiment

BP’s London‑listed shares eased lower on Friday as the fallout from a major U.S. pipeline leak and another drop in global oil prices weighed on the BP plc share price. BP share price today: how BP.L traded on 21 November 2025 At the close in London on Friday 21 November 2025, data from several market platforms showed BP plc (ticker…
21 November 2025
····
Rolls-Royce (RR.L) Today: RBC ‘Outperform’ Call, Etihad Engine Deal and Emirates Snub Shape Outlook – 18 November 2025

Rolls-Royce Share Price Today (21 November 2025): LON: RR Slides Despite Moody’s Upgrade and Emirates Deal

Rolls-Royce Holdings plc (LON: RR.) shares are easing back today after a powerful run in 2025, even as a wave of positive news — including a credit rating upgrade and fresh aviation deals — continues to reshape the long‑term investment story. Rolls-Royce share price today: 21 November 2025 snapshot As of the London close on 21 November 2025, Rolls-Royce Holdings plc…
21 November 2025
····
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

US Stock Market Today: Futures Rebound After AI Rout – 7 Things to Know Before the Bell (Nov. 21, 2025)

U.S. equity futures are pointing to a cautious rebound on Friday, November 21, 2025, after a violent tech-led selloff and historic intraday reversal rattled Wall Street on Thursday. As of around 3:58 a.m. ET, futures tied to the Nasdaq 100, S&P 500 and Dow Jones were up about 0.17%, 0.31% and 0.43%, respectively, following sharp declines in the main indexes…
21 November 2025
····
CBA (ASX:CBA) before the bell: What to know about Commonwealth Bank of Australia stock ahead of the ASX open on 17 Nov 2025

CBA Share Price Today 21 November 2025: Commonwealth Bank Faces Valuation Fears, Political Heat and Housing Jitters

Commonwealth Bank of Australia (ASX: CBA) heads into Friday 21 November 2025 still under pressure after one of its sharpest sell‑offs in years, as investors juggle three big storylines: stretched valuations, political scrutiny over “excessive” fees, and growing concern about Australia’s overheated housing market. At Thursday’s close, CBA shares were trading around A$153, up slightly on the day but still roughly 16–20%…
21 November 2025
····
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

D-Wave Quantum (QBTS) Stock Today: 12% Slide as Liquidity Fears, Warrant Overhang and Insider Selling Hit the Quantum High‑Flyer (20 November 2025)

D‑Wave Quantum Inc. (NYSE: QBTS), one of 2025’s most volatile “pure‑play” quantum computing stocks, suffered another steep sell‑off on Thursday, 20 November 2025, as investors digested Q3 results, a completed warrant‑redemption deadline, fresh insider‑sale headlines and new short‑interest data. Below is a full breakdown of how QBTS traded today, what drove the move, and how Wall Street is reacting. D‑Wave…
20 November 2025
····
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Today (November 20, 2025): Price Slides After AI Rally as IRAP Win, New U.S. Army Deal and Analyst Split Shape the Story

Updated: November 20, 2025 Palantir Technologies (NASDAQ: PLTR) remains at the center of the artificial intelligence (AI) trade — but today’s action shows just how volatile that trade has become. After touching all‑time highs earlier this month, Palantir stock has pulled back more than 20% while still sitting on a triple‑digit gain for 2025. Trefis At the same time, the company…
20 November 2025
····
Inspire Veterinary Partners (IVP) Plunges Over 60%, Then Rebounds as Nasdaq Delisting Deadline Hits Today

Inspire Veterinary Partners (IVP) Plunges Over 60%, Then Rebounds as Nasdaq Delisting Deadline Hits Today

On Thursday, November 20, 2025, Inspire Veterinary Partners, Inc. (Nasdaq: IVP) sits at the center of one of the most volatile micro‑cap stories on the market, with its stock whipsawing after a Nasdaq delisting notice and a critical appeal deadline that falls today. SEC After collapsing more than 58–62% on Wednesday to near its 52‑week low following news of the…
20 November 2025
···
Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions Inc. (NYSE: J) kicked off Thursday’s trading session with a flurry of news: stronger‑than‑expected fiscal fourth‑quarter 2025 results, a bullish 2026 earnings outlook, fresh SEC filings, and continued shareholder returns via dividends and buybacks. The engineering and professional services company reported solid top‑line growth, expanding margins on an adjusted basis and a record backlog, even as GAAP profit…
20 November 2025
···
Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio Inc. has become one of the hottest tickers in biotech this week. On November 20, 2025, NUVB is trading near a three‑year high after a powerful earnings beat, accelerating uptake of its lung‑cancer drug IBTROZI™ (taletrectinib), and a wave of bullish analyst upgrades that continue to roll in today. Seeking Alpha At the time of writing, Nuvation Bio…
20 November 2025
····
PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group, Inc. (NYSE:PACS) is back in the spotlight on Thursday after delivering strong third‑quarter 2025 results, completing a high‑stakes financial restatement process and unveiling upbeat guidance that has sent the stock to fresh 52‑week highs. PACS Group, Inc. The post‑acute care operator’s shares have surged this week as investors digest a rare combination of record revenue growth, restored SEC…
20 November 2025
····
Block, Inc. (XYZ) Stock Jumps on $5 Billion Buyback and Bold 2028 Profit Targets – 20 November 2025

Block, Inc. (XYZ) Stock Jumps on $5 Billion Buyback and Bold 2028 Profit Targets – 20 November 2025

Block, Inc. (NYSE: XYZ) — the Jack Dorsey‑led fintech behind Cash App and Square — is back in the spotlight today after unveiling an ambitious three‑year growth roadmap and a fresh $5 billion share repurchase authorization. The new plan, presented at the company’s 2025 Investor Day, has sent the stock up roughly 7–9% as investors reassess the beaten‑down fintech name.…
20 November 2025
····
1 … 192 193 194 195 196 … 231

Stock Market Today

  • Truist Financial (TFC) Stock Slides 1.5%, Trades 23% Below Fair Value
    January 24, 2026, 12:59 PM EST. Truist Financial (TFC) shares fell 1.5% in the past day and 2.3% over the last month, even as its three-month total return stands at 12.2%. The stock trades at $49.57, approximately 23% below an estimated fair value of $55.11, suggesting potential undervaluation. Analysts point to ongoing technology investments aimed at improving efficiency and reducing costs, which could boost future earnings. However, risks include rising credit losses in the commercial real estate portfolio and increased branch and technology expenses. Investors are cautioned to weigh these factors carefully as recent share price momentum cools and market uncertainties persist.
Go toTop